BIOSPECIFICS TECHNOLOGIES CORP·4

Jan 10, 7:41 PM ET

HUTCHISON PATRICK 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Jan 10, 2020

Insider Transaction Report

Form 4
Period: 2020-01-06
Hutchison Patrick
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-06+10,00010,000 total
    Exercise: $56.21Exp: 2030-01-06Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]The stock options were granted under the BioSpecifics Technologies Corp. 2019 Omnibus Incentive Compensation Plan. This transaction is reported late due to delayed receipt of the Reporting Person's EDGAR access codes.
  • [F2]The stock options vest ratably over the four-year period following the date of grant, January 6, 2020, subject to the Reporting Person's continued service to the employer through the vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES